Skip to main content
HomeEventsMPhA Annual Spring Conference

Events - Event View

MPhA Annual Spring Conference

warning If you are a member, please log in to access member benefits, if available. close

Date and Time

Tuesday, April 14, 2026, 8:00 AM until 5:00 PM

Location

Sheraton Four Points Norwood
1125 Boston Providence Turnpike
Norwood, MA  
USA

Category

Continuing Education

Registration Info

Registration is required
Payment In Full In Advance Only

About this event

 

April Spring Conference

Continuing Pharmacy Education

for Pharmacists and Pharmacy Technicians

Four Points Sheraton Hotel – Norwood, MA

Tuesday, April 14th, 2026 – 7:00 AM – 5:00 PM

 

 

7:00 AM        Welcome

8:10 AM        Best Practices for Dispensing Compounded Drugs: A Deep Dive, Tenille Davis, PharmD, RPh, BCSCP, FAPC

9:15 AM        Update on 2025 Hypertension Guidelines, Erika Getzik, PharmD, RPh

10:15 AM       Break – Exhibit Hall Opens

10:30 AM       Sterile Compounding Compliance Overview, Michelle Chan, RPh – Board of Registration in Pharmacy

11:35 AM      Pipeline Preview 2026, Maria Lowe, PharmD, RPh

12:35 PM      Lunch - Exhibit Hall Open

1:40 PM        Wellness in the Workplace, Kerrie Toole, LICSW

2:45 PM        Updates on AI Advancements in Pharmacy Practice, Tim Aungst, PharmD

3:45PM         Afternoon Break

3:50 PM        Legislative and Regulatory Policies and Pharmacy Practice, Maria Sosa, Esq

 

Learning Objectives:

After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

Best Practices for Dispensing Compounded Drugs: A Deep Dive      

Tenille Davis, PharmD, RPh, BCSCP, FAPC

  • Identify key legal and professional requirements for dispensing compounded medications pursuant to patient-specific prescriptions.
  • Describe best practices for labeling and packaging compounded medications to promote patient understanding and proper use.
  • Give examples of effective patient counseling strategies specific to compounded therapies, including dosing, administration, storage, and follow-up considerations.
  • Explain the difference between dispensing responsibilities for compounded medications from those applicable to FDA-approved manufactured drugs.
  • Compile documentation and quality assurance practices that support compliant dispensing and continuity of care.

UAN: 0674-9999-26-002-L07-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-002-L07-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

 

 

Update on 2025 Hypertension Guidelines

Erika Getzik, PharmD, RPh

After participating in this learning activity, pharmacists should be able to:

  • Determine a hypertensive patient’s blood pressure (BP) goal
  • Calculate the PREVENT score to determine BP treatment initiation in patients with Stage I hypertension
  • Apply the guidelines to appropriately treat non-pregnant and pregnant patients with hypertension

UAN: 0674-9999-26-003-L01-P (1 contact hour – 0.1 CEU) Application Based – Pharmacists

  • Describe a BP goal for a patient with hypertension
  • Explain the purpose of PREVENT score calculations in the treatment of Stage I hypertension
  • Read the updated 2025 Hypertension Guidelines for the treatment of bon-pregnant and pregnant patients with hypertension

UAN: 0674-9999-26-010-L01-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

 

Sterile Compounding Compliance Overview

Board of Pharmacy Law Update 

Michelle Chan, RPh

After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

  • Identify requirements for sterile compounding areas.
  • Summarize key points of sterile compounding practices from advisories and policies.
  • Recognize common inspectional deficiencies.

UAN: 0674-9999-26-004-L03-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-004-L03-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

Pipeline Preview 2026

Maria Lowe, PharmD, RPh, BCPS After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

  • Describe recent trends related to FDA approvals and drug regulation in the US
  • Identify agents in late stages of development across select therapeutic areas
  • List the first-time generics expected to hit the market within the next two years

UAN: 0674-9999-26-005-L04-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-005-L04-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

Wellness in the Workplace

Kerrie Toole, LICSW

After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

  • Identify at least three occupational sensors and systematic challenges that contribute to elevated suicide risk and burnout among pharmacists and pharmacy technicians, as supported by current peer reviewed literature.
  • Explain the appropriate State of Mind (Emotional Mind, Rational Mind or Wise Mind) for making effective decisions under occupational or personal stress.
  • Give examples of at least two self-regulating coping strategies to manage stress responses in the pharmacy work environment, including proactive and reactive approaches
  • Summarize strategies from the six-core resilience building domains: self-care, self-awareness, self-regulation, coping strategies, social connection and resilient mindset to build a personal resilience plan
  • Identify at least two professional mental health resources available to pharmacists and pharmacy technicians in need of behavioral health support or crisis intervention

UAN: 0674-9999-26-007-L04-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-007-L04-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

Updates on AI Advancements in Pharmacy Practice

Tim Aungst, PharmD, RPh

After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

  • Define key AI terminology in relationship to pharmacy practice
  • Identify key AI technologies being adopted into the pharmacy practice workforce and ongoing research and development
  • Describe what limitations are present in current AI tools and how those impact current practice with AI adoption

UAN: 0674-9999-26-006-L04-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-006-L04-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

Legislative and Regulatory Policies and Pharmacy Practice

Maria Sosa, Esq. 

Attorney/Managing Partner

Lanton, Lanton & Sosa Law PLLC

After participating in this activity, Pharmacist & Pharmacy Technicians should be able to:

  • Identify pending Pharmacy legislative and regulatory policies including State Law, Board of Registration in Pharmacy Regulations and Federal Pharmacy and Drug Laws that are under consideration.
  • Explain how these policies could affect the practice of pharmacy.
  • Describe how these policies may affect specific practices areas.
  • Give examples from practice of solutions that may help mitigate some of these policies

UAN: 0674-9999-26-008-L03-P (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacists

UAN: 0674-9999-26-008-L03-T (1 contact hour – 0.1 CEU) Knowledge Based – Pharmacy Technicians

 

Fee Information:    MPhA MEMBERS ONLY: $125.00

Non-Members: $199.00

Bundle - Meeting Registration and Membership: $250.00

 

Registration Link: Click Here to Register

 

 

 

 

 

 

 

How To Earn Credit:

  • Attend learning activities
  • Complete the evaluation and learning assessment directly after the activity or within a maximum within 60 days – no credit will be given for late submissions
  • Provide your date of birth and NABP number for verification purposes
  • Credits will be automatically transferred from Lecture Panda to NABP CPE Monitor within 30 days
  • No Statements of Credit will be issued

 

Accreditation Statement

Pharmacy: EMO is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Number of People Who Will Attend

Non Member *
$199.00
Membership Bundle
$250.00
* This can be your primary registrant type. Only one primary registrant type is allowed per registration.
Register Now